PACIRA PHARMACEUTICALS INC recalls

3 recalls on record · latest: June 12, 2024

Official U.S. recall history for PACIRA PHARMACEUTICALS INC, compiled from official government records.

Get recall alerts

Free email alert whenever PACIRA PHARMACEUTICALS INC has a new recall — straight from official government data. Unsubscribe anytime.

PACIRA PHARMACEUTICALS INC recalls Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: P…

June 12, 2024 · Drug & medication recalls Moderate risk Failed Dissolution Specifications - did not meet the acceptance criteria for IV…

PACIRA PHARMACEUTICALS INC recalls Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, M…

May 7, 2024 · Drug & medication recalls Moderate risk Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 week…

Pacira Pharmaceuticals, Inc. recalls EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manuf…

November 21, 2019 · Drug & medication recalls Moderate risk Sub Potent Drug: Out of Specification (OOS)